3-methylpentane-1,5-diol

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in mammalian cells

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2005

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Remarks:

The study was conducted according to an appropriate OECD test method and in compliance with GLP.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2005

Report date:

2005

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)

GLP compliance:

yes (incl. QA statement)

Type of assay:

mammalian cell gene mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

3-methylpentane-1,5-diol

EC Number:

224-709-1

EC Name:

3-methylpentane-1,5-diol

Cas Number:

4457-71-0

Molecular formula:

C6H14O2

IUPAC Name:

3-methylpentane-1,5-diol

Specific details on test material used for the study:

- Name of test material (as cited in study report): 3-methyl-1,5-pentanediol (MPD)
- Molecular formula (if other than submission substance): C6H14O2
- Molecular weight (if other than submission substance): 118
- Physical state: transparent liquid
- Analytical purity: 99.3 %
- Purity test date: 2005-03-14
- Lot/batch No.: 62626 (supplier Kuraray Co. Ltd, Japan)
- Expiration date of the lot/batch: 2005-09-05
- Storage condition of test material: ambient temperature, dark

Method

Target gene:

TK locus

Species / strain

Species / strain / cell type:

mouse lymphoma L5178Y cells

Metabolic activation:

with and without

Metabolic activation system:

S9 mix

Test concentrations with justification for top dose:

range finding test: 0.61, 1.2, 2.4, 4.9, 7.0, 10 (mmol/L) (with and without met. act.)
main test: 0, 1.2, 2.4, 4.9, 7.0, 10 (mmol/L) (with and without met. act.)

Vehicle / solvent:

- Vehicle(s)/solvent(s) used: the test substance was diluted in DMSO; the test was carried out in culture medium (RPMI 1640; with HEPES and Glutamax-I), supplemented with heat-inactivated horse serum (10 % v/v), sodium pyruvate and penicillin/streptomycin

Controls

Controls 1

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

methylmethanesulfonate

Remarks:

without activation: 100, 200 µmol/L

Controls 2

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

3-methylcholanthrene

Remarks:

with activation: 10 µl/L

Details on test system and experimental conditions:

DURATION
- Exposure duration: 24 hours at 37°C (without activation) and 4 hours at 37°C (with activation)
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 10-14 days


SELECTION AGENT (mutation assays): trifluorothymidine (TFT)

NUMBER OF REPLICATIONS: two


DETERMINATION OF CYTOTOXICITY
- Method: relative total growth

Evaluation criteria:

A response was considered to be positive if the induced mutant frequency (mutant frequency of the test substance minus that of the vehicle negative control) was more than 100 mutants per 1000000 clonable cells. A response was considered to be equivocal if the induced mutant frequency was more than 50 mutants per 1000000 clonable cells. Any apparent increase in mutant frequency at concentrations of the test substance causing more than 90 % cytotoxicity was considered to be an artefact and not indicative of genotoxicity.
The test substance was considered to be mutagenic in the gene mutation test at the TK-locus if it produced neither a dose-related increase in the mutant frequency nor a reproducible positive response at any of the test points.

Statistics:

No statistical analysis was performed

Results and discussion

Test results

Species / strain:

mouse lymphoma L5178Y cells

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

other: all strains/cell types tested

Any other information on results incl. tables

In both the absence and presence of S9-mix no increases of the mean mutant frequency by more than 50 mutants per 1000000 clonable cells compared to negative control were observed. As exspected, the cultures treated with the positive controls exhibited significant increases in mutation frequency relative to their solvent control cultures.

Summary of the results:

Dose (mmol/L)	absence of S9		presence of S9
	mean MF	Mean RTG	mean MF	RTG
10	117	179	117	85
7	154	135	83	80
4.9	121	145	111	88
2.4	103	139	145	90
1.2	138	109	127	96
0	171	100	118	100

Positive and negative controls

Methyl methanesulphonate (MMS) and 3 -methylcholanthrene (MCA) were used as positive control substances in the absence and in the presence of the S9 -mix, respectively. DMSO served as negative control. The negative controls were within acceptable ranges and treatment with the positive controls yielded the exspected significant increase in mutant frequency compared to the negative control.

Applicant's summary and conclusion

Conclusions:

Interpretation of results:
negative with metabolic activation
negative without metabolic activation

In conclusion, 3-methyl-1,5-pentane-diol is not mutagenic at the TK-locus of mouse lymphoma L5178Y cells under the conditions in this study.

Executive summary:

MPD was examined for its potential to induce gene mutataions at the TK-locus of cultured mouse lymphoma L5178Y cells in both absence and presence of metabolic activation system (S9 -mix). One assay was conducted; in the assay five concentrations were tested in duplicate in both absence and presence of S9 -mix. The test substance was diluted in DMSO prior to testing.

The highest concentration tested and evaluated for mutagenicity was 10 mmol/l in both the absence and presence of S9 -mix.

MPD was not cytotoxic to L5178Y. The relative total growth at the highest concentration was not decreased compared to the negative control. No increase of mutant frequency was observed at any dose level. Methyl methansulphonate MMS and 3 -methylcholanthrene were used as positive controls, respectively. Treatment with controls yielded the expected significant increase in mutant frequency.

Under the conditions of the study the test substance MPD is not mutagenic at the TK-locus of mouse lymphoma L5178Y cells.